WO2002081681A1 - Nouvelle utilisation de la cytokine sf20 - Google Patents

Nouvelle utilisation de la cytokine sf20 Download PDF

Info

Publication number
WO2002081681A1
WO2002081681A1 PCT/JP2002/002768 JP0202768W WO02081681A1 WO 2002081681 A1 WO2002081681 A1 WO 2002081681A1 JP 0202768 W JP0202768 W JP 0202768W WO 02081681 A1 WO02081681 A1 WO 02081681A1
Authority
WO
WIPO (PCT)
Prior art keywords
cytokine
novel use
tsa
proliferation
receptor
Prior art date
Application number
PCT/JP2002/002768
Other languages
English (en)
Japanese (ja)
Inventor
Edgardo E. Tulin
Nobuhisa Onoda
Masatsugu Maeda
Yasuhiko Nakata
Masakazu Hasegawa
Hitoshi Nomura
Original Assignee
Chugai Seiyaku Kabushiki Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Seiyaku Kabushiki Kaisha filed Critical Chugai Seiyaku Kabushiki Kaisha
Publication of WO2002081681A1 publication Critical patent/WO2002081681A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Il a été découvert que la cytokine SF20 est un ligand naturel de TSA-1, lequel est un récepteur, et favorise la prolifération de cellules exprimant TSA-1.
PCT/JP2002/002768 2001-03-30 2002-03-22 Nouvelle utilisation de la cytokine sf20 WO2002081681A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001102394 2001-03-30
JP2001-102394 2001-03-30

Publications (1)

Publication Number Publication Date
WO2002081681A1 true WO2002081681A1 (fr) 2002-10-17

Family

ID=18955603

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2002/002768 WO2002081681A1 (fr) 2001-03-30 2002-03-22 Nouvelle utilisation de la cytokine sf20

Country Status (1)

Country Link
WO (1) WO2002081681A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014111458A3 (fr) * 2013-01-17 2014-09-12 Medizinische Hochschule Hannover Protéine du facteur 1, protéine du facteur 2 et leurs inhibiteurs destinés à être utilisés dans le traitement ou la prévention de maladies

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19813839A1 (de) * 1998-03-20 1999-09-23 Metagen Gesellschaft Fuer Genomforschung Mbh Menschliche Nukleinsäuresequenzen aus Brusttumorgewebe
WO2000073442A1 (fr) * 1999-06-01 2000-12-07 Chugai Research Institute For Molecular Medicine, Inc. Nouvelle cytokine

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19813839A1 (de) * 1998-03-20 1999-09-23 Metagen Gesellschaft Fuer Genomforschung Mbh Menschliche Nukleinsäuresequenzen aus Brusttumorgewebe
WO2000073442A1 (fr) * 1999-06-01 2000-12-07 Chugai Research Institute For Molecular Medicine, Inc. Nouvelle cytokine

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014111458A3 (fr) * 2013-01-17 2014-09-12 Medizinische Hochschule Hannover Protéine du facteur 1, protéine du facteur 2 et leurs inhibiteurs destinés à être utilisés dans le traitement ou la prévention de maladies
JP2016506911A (ja) * 2013-01-17 2016-03-07 メディツィーニシェ・ホーホシューレ・ハノーファーＭｅｄｉｚｉｎｉｓｃｈｅ Ｈｏｃｈｓｃｈｕｌｅ Ｈａｎｎｏｖｅｒ 疾患の治療または予防に用いるためのファクター１およびファクター２タンパク質、およびその阻害剤
JP2020203894A (ja) * 2013-01-17 2020-12-24 メディツィーニシェ・ホーホシューレ・ハノーファーＭｅｄｉｚｉｎｉｓｃｈｅ Ｈｏｃｈｓｃｈｕｌｅ Ｈａｎｎｏｖｅｒ 疾患の治療または予防に用いるためのファクター１およびファクター２タンパク質、およびその阻害剤
EP3747457A3 (fr) * 2013-01-17 2021-03-03 Medizinische Hochschule Hannover Protéine du facteur 1, protéine du facteur 2 et leurs inhibiteurs destinés à être utilisés dans le traitement ou la prévention de maladies

Similar Documents

Publication Publication Date Title
AU2003276847A1 (en) Polymers, supersoft elastomers and methods for preparing the same
AU2002310741A1 (en) Superabsorber, method for the production and use thereof
MX260863B (es) Catalizadores que contienen plata, su elaboracion y uso de los mismos.
ZA200204020B (en) Use of anti-CTLA-4-antibodies.
ZA200303243B (en) Supported mixed metal oxide catalyst.
ZA200306530B (en) Foamer.
MXPA03007408A (es) Proceso de polimerizacion.
AU2003255797A1 (en) Supported polymerisation catalysts
EG23387A (en) Spirocyclic 3-phenyl-3-substituted 4-ketolactams and-lactones.
MXPA03008706A (es) Encendedor multimodal.
CA97633S (en) Trimmer
ZA200206403B (en) Spice crusher.
CA97340S (en) Barbecue tongs
AU2002240902A1 (en) Mat, and device for producing said mat
WO2002081681A1 (fr) Nouvelle utilisation de la cytokine sf20
AU2003214985A1 (en) Polymerized wax candles
MXPA03007888A (es) Compuestos para tratamiento y prevencion de ulcera gastrica inducida por medicamentos.
GB2379960B (en) Toroidal continuously variable transmission.
CA111738S (en) Binder
AU2003275127A1 (en) P. ariasi polypeptides, p. perniciosus polypeptides and methods of use
AU2003232740A1 (en) Graft copolymers based on polyurethane, the production thereof, and the use of the same
AU2003253004A1 (en) Supported polymerisation catalysts
HK1054779A1 (en) Gas range.
AU2003269082A8 (en) Food base for fritters, method for the production thereof, and uses thereof
AU2002324837A1 (en) Promoted catalysts and fischer-tropsch processes

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WA Withdrawal of international application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP